XERS News and Press, Xeris Pharmaceuticals Inc. From 03/26/20

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced a limited-time $0 copay offering for commercially eligible...

GVOKE Pre-Filled Syringe (PFS) is available for home delivery through PillPack by Amazon Pharmacy Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable an...

Image source: The Motley Fool. Xeris Pharmaceuticals, Inc.   (NASDAQ: XERS) Q4 2019 Earnings Call Mar 11, 2020 , 8:30 a.m. ET Operator Continue reading

Xeris Pharmaceuticals, Inc. (XERS) Q4 2019 Results Earnings Conference Call March 11, 2020, 08:30 AM ET Company Participants Allison Wey - Senior Vice President of Investor Relations and Corporate Communications Paul Edick - Chairman & Chief Executive Officer Barry Deutsch - ...

Xeris Pharmaceuticals (NASDAQ: XERS ): Q4 GAAP EPS of -$1.23 misses by $0.08 . Revenue of $1.63M beats by $0.97M . Shares +4% PM. Press Release More news on: Xeris Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, ,

GVOKE™ PFS net sales of $1.6 million in Q4 2019 GVOKE HypoPen™ on track for planned launch in July 2020 All current clinical programs expected to report topline results in 1H 2020 Conference call and webcast today at 8:30 a.m. ET Xeris Pharmaceuticals, In...

CHICAGO, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that the Comp...

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that, in connection with its previously announced underwritten public ...

Viveve Medical (NASDAQ: VIVE ) +35% . More news on: Viveve Medical, Inc., Quad/Graphics, Inc., Myomo, Inc., Stocks on the move, Read more ...

Zosano Pharma (NASDAQ: ZSAN )  -47%  after pricing stock offering. More news on: Zosano Pharma Corporation, PolarityTE, Inc., PDS Biotechnology Corporation, Stocks on the move, , Read more ...